Introduction to testicular cancer related knowledge

Our ideal life is very beautiful, but the reality is very cruel. Not only will there be unsatisfactory things happen, but there will also be unbearable diseases. Testicular cancer is a very harmful disease, not only because it is a malignant tumor, but also because its incidence population tends to be young and middle-aged people in their prime. So, let's learn about the relevant knowledge of testicular cancer.

First of all, testicular cancer occurs in young and middle-aged people. Although the cure rate is high, it has a great impact on society and family. The treatment process of testicular tumors requires the removal of the affected testicle. The subsequent retroperitoneal lymph node dissection surgery, radiotherapy or chemotherapy will bring corresponding adverse reactions, which may affect the patient's reproductive function.

Testicular cancer has no obvious symptoms in the early stage. The typical clinical manifestation is a gradually enlarging painless mass, which is discovered accidentally by the patient himself, his family or the doctor during routine examination. Half of the patients often feel that the testicles are heavy, and sometimes feel a pulling sensation in the scrotum, lower abdomen or groin, which is obvious when jumping or running. After standing for too long or being tired, local symptoms will be aggravated with a feeling of falling or mild pain. When there is an accidental collision or squeezing, the pain will be aggravated, which will attract the patient's attention and prompt him to seek medical treatment. Some patients often have symptoms similar to acute orchitis or epididymitis. After anti-inflammatory treatment, although the inflammation has been controlled, there is a mass that does not disappear. At this time, you should be alert to the possibility of testicular cancer.

Testicular cancer occurs in testicular tissue, has a complex pathological origin, and is relatively rare clinically, accounting for about 1% of all male malignant tumors. The main incidence population is young men in their fertility peak, so it has a relatively large impact on society. However, the cure rate of testicular cancer is very high, with a survival rate of 95% or even higher. Therefore, in the field of oncology, testicular cancer is a very important malignant tumor.

Due to the improvement of diagnostic technology, the decrease of staging error, and the great success of DDP-based combination chemotherapy, the survival rate of patients with testicular germ cell tumors, especially testicular germ cell cancer, has been greatly improved. The 5-year survival rate has increased from 60% to 70% in the 1960s to more than 90% at present. At the same time, treatment strategies have also undergone major changes.

With the modern improved nerve-protecting unilateral retroperitoneal lymph node dissection, 80% of patients still retain their reproductive function and fertility, so many treatment centers still advocate the continued use of orchiectomy plus retroperitoneal lymph node dissection to treat clinical testicular cancer. Another alternative treatment for clinical testicular cancer is radiotherapy or chemotherapy, which has the same efficacy as lymph node dissection, but can better protect the patient's sexual function and fertility.